Working with TipRanks
Follow Us
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Akebia Therapeutics (AKBA)
NASDAQ:AKBA
Akebia Therapeutics (AKBA) Financial Statements
859 Followers
Akebia Therapeutics Financial Overview
| Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 42.24M | $ 40.13M | $ 55.18M | $ 48.96M | $ 126.76M |
| Gross Profit | $ 48.10M | $ 40.13M | $ 55.18M | $ 11.02M | $ 108.16M |
| EBIT | $ -9.27M | $ -15.74M | $ -15.51M | $ -47.91M | $ 34.31M |
| EBITDA | $ 123.00K | $ -6.35M | $ 42.26M | $ -38.49M | $ 43.74M |
| Net Income Common Stockholders | $ -11.17M | $ -26.22M | $ -7.55M | $ -51.87M | $ 29.28M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 53.57M | $ 57.00M | $ 90.47M | $ 144.76M | $ 143.89M |
| Total Assets | $ 253.67M | $ 276.86M | $ 351.83M | $ 435.89M | $ 521.80M |
| Total Debt | $ 53.97M | $ 77.71M | $ 95.04M | $ 100.89M | $ 134.31M |
| Net Debt | $ 394.00K | $ 20.71M | $ 4.57M | $ -43.87M | $ -9.58M |
| Total Liabilities | $ 280.52M | $ 291.21M | $ 342.49M | $ 422.04M | $ 459.50M |
| Stockholders Equity | $ -26.81M | $ -14.35M | $ 9.34M | $ 13.85M | $ 62.30M |
| Cash Flow | - | ||||
| Free Cash Flow | $ 3.64M | $ -17.58M | $ -54.68M | $ 33.80M | $ -30.66M |
| Operating Cash Flow | $ 3.64M | $ -17.58M | $ -54.68M | $ 33.80M | $ -30.66M |
| Investing Cash Flow | - | - | - | $ 0.00 | $ 0.00 |
| Financing Cash Flow | $ -8.00M | $ -15.97M | $ -1.00K | $ -32.94M | $ -9.00K |